William P. Burke
2018
In 2018, William P. Burke earned a total compensation of $2M as Executive Vice President, Chief Financial Officer at Haemonetics, a 18% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $506,735 |
|---|---|
| Option Awards | $232,494 |
| Salary | $482,328 |
| Stock Awards | $765,142 |
| Other | $18,049 |
| Total | $2,004,748 |
Burke received $765.1K in stock awards, accounting for 38% of the total pay in 2018.
Burke also received $506.7K in non-equity incentive plan, $232.5K in option awards, $482.3K in salary and $18K in other compensation.
Rankings
In 2018, William P. Burke's compensation ranked 5,736th out of 14,244 executives tracked by ExecPay. In other words, Burke earned more than 59.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,736 out of 14,244 | 60th |
Division Manufacturing | 2,172 out of 5,765 | 62nd |
Major group Measuring, Analyzing, And Controlling Instruments; Photographic, Medical And Optical Goods; Watches And Clocks | 269 out of 849 | 68th |
Industry group Surgical, Medical, And Dental Instruments And Supplies | 147 out of 547 | 73rd |
Industry Surgical and Medical Instruments and Apparatus | 93 out of 348 | 73rd |
Source: SEC filing on June 12, 2019.
Burke's colleagues
We found three more compensation records of executives who worked with William P. Burke at Haemonetics in 2018.
News
Haemonetics CEO Christopher Simon's 2022 pay rises 1% to $8.7M
June 17, 2022
Haemonetics CEO Christopher Simon's 2021 pay slips 8% to $8.6M
June 17, 2021
Haemonetics CEO Christopher Simon's 2020 pay rises 10% to $9.4M
June 8, 2020
Haemonetics CEO Christopher Simon's 2019 pay rises 9% to $8.6M
June 12, 2019